NR2B-containing NMDA receptors are upregulated in temporal cortex in schizophrenia

NeuroReport

Volumn 10, Issue 3, 1999, Pages 461-465

  Grimwood, Sarah ^a   Slater, Paul ^b   Deakin, J F William ^b   Hutson, Pete H ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Glutamate; Human superior temporal cortex; NMDA receptor; NR2B subunit; Radioligand binding; Schizophrenia

Indexed keywords

2 AMINO 4 PHOSPHONOMETHYL 3 HEPTENOIC ACID; 5,7 DICHLORO 1,2,3,4 TETRAHYDRO 4 (3 PHENYLUREIDO) 2 QUINOLINECARBOXYLIC ACID; GLUTAMIC ACID; GLYCINE; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TRITIUM;

ADULT; AGED; ARTICLE; CADAVER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PREMOTOR CORTEX; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SCHIZOPHRENIA; TEMPORAL CORTEX;

EID: 0033601963     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199902250-00004     Document Type: Article

References (24)

1. 1. Kim JS, Kornhuber HH, Schmid-Burgk W and Holzmūller B. Neurosci Lett 20, 379-382 (1980).
2. 2. Javitt DC and Zukin SR. Am J Psychiatry 148, 1301-1308 (1991).
3. 3. Lidsky TI and Banerjee SP. Drugs News Persp 8, 453-459 (1996).
4. 4. Hirsch SR, Das I, Garey LJ and de Belleroche J. Pharmacol Biochem Behav 56, 797-802 (1997).
5. 5. McBain CJ and Mayer ML. Physiol Rev 74, 723-760 (1994).
6. 6. Kornhuber J, Mack-Burkhardt F, Riederer P et al. J Neural Transm 77, 231-236 (1989).
7. 7. Toru M, Kurumaji A, Kumashiro S et al. Mol Neuropharmacol 2, 241-243 (1992).
8. 8. Simpson MDC, Slater P, Royston MC and Deakin JFW. Schiz Res 6, 41-48 (1992).
9. 9. Kerwin R, Patel S and Meldrum B. Neuroscience 39, 25-21 (1990).
10. 10. Ishimaru M, Kurumaji A and Toru M. Biol Psychiatry 35, 84-95 (1994).
11. 11. Aparicio-Legarza MI, Davis B, Hutson PH and Reynolds GP. Neurosci Lett 241, 143-146 (1998).
12. 12. Akbarian S, Sucher NJ, Bradley D et al. J Neurosci 16, 19-30 (1996).
13. 13. Humphries C, Mortimer A, Hirsch S, and de Belleroche J. NeuroReport 7, 2051-2055 (1996).
14. 14. Whiting PJ and Priestley T. The molecular biology of NMDA type glutamate receptors. In: Turner AJ and Stephenson FA, eds. Amino Acid Neurotransmission. London: Portland Press, 1998: 153-176.
15. 15. Laurie DJ and Seeburg PH. Bur J Pharmacol Mol Phamacol 268, 335-345 (1994).
16. 16. Priestley T, Laugnton P, Myers J et al. Mol Phamacol 48, 841-848 (1996).
17. 17. Grimwood S, Gilbert E, Ragan CI and Hutson PH. J Neurochem 66, 2589-2595 (1996).
18. 18. Monyer H, Sprengel R, Schoepfer R et al. Science 256, 1217-1221 (1992).
19. 19. Rigby M, Le Bourdellès B, Heavens RP et al. Neuroscience 73, 429-447 (1998).
20. 20. Grimwood S, Le Bourdellès B and Whiting PJ. J Neurochem 64, 525-530 (1995).
21. 21. Grimwood S, Le Bourdellès B, Atack JR et al. J Neurochem 66, 2239-2247 (1996).
22. 22. Williams K, Russell SL, Shen YM et al. Neuron 10, 267 (1993).
23. 23. Richards P, Hutson PH and Grimwood S. Br J Pharmacol Proc Suppl 124, 61P (1998).
24. 24. Kew JNC, Richards JG, Mutel V and Kemp JA. J Neurosci 18, 1935-1943 (1998).